Selected article for: "cell adhesion and migration cell adhesion"

Author: Park, Pyong Woo
Title: Extracellular Matrix: Surface Proteoglycans
  • Cord-id: dy749eht
  • Document date: 2020_5_28
  • ID: dy749eht
    Snippet: Cell surface proteoglycans, such as syndecans and glypicans, regulate molecular interactions that mediate cell adhesion, migration, proliferation, and differentiation. Through these activities, surface proteoglycans modulate critical biological processes of development, inflammation, infection, tissue repair, and cancer metastasis. Proteoglycans are unique glycoproteins comprised of one or several glycosaminoglycans attached covalently to core proteins. Glycosaminoglycans mediate the majority of
    Document: Cell surface proteoglycans, such as syndecans and glypicans, regulate molecular interactions that mediate cell adhesion, migration, proliferation, and differentiation. Through these activities, surface proteoglycans modulate critical biological processes of development, inflammation, infection, tissue repair, and cancer metastasis. Proteoglycans are unique glycoproteins comprised of one or several glycosaminoglycans attached covalently to core proteins. Glycosaminoglycans mediate the majority of ligand-binding functions of proteoglycans. Accumulating evidence indicates that surface proteoglycans regulate the onset, progression, and outcome of lung diseases, including lung injury, infection, fibrosis, and cancer. This article will review key features of surface proteoglycan biology in lung health and disease.

    Search related documents:
    Co phrase search for related documents
    • aberrant activation and acute lung injury: 1, 2, 3, 4
    • aberrant activation and additional study: 1
    • aberrant activation and low expression: 1, 2, 3
    • aberrant activation and lung cancer: 1, 2
    • aberrant activation and lung carcinoma: 1
    • aberrant activation and lung development: 1
    • aberrant activation and lung disease: 1, 2, 3
    • aberrant activation and lung endothelial: 1, 2, 3
    • aberrant activation and lung infection: 1, 2
    • aberrant activation and lung inflammation: 1
    • aberrant activation and lung injury: 1, 2, 3, 4, 5, 6, 7